Real-World Clinical and Patient-Reported Outcomes from the Longitudinal Telotristat Ethyl Treatment Registry of Patients with Neuroendocrine Tumors.

Daneng LiChristina DardenNoran OsmanSalma SayeedLaurin JacksonDiana GarbinskyAman Chauhan

Published in: Cancer management and research (2022)

This longitudinal observational study showed improvements in real-world clinical and humanistic outcomes for patients with CS and at least 6 months of TE treatment.

Keyphrases

patient reported outcomes
neuroendocrine tumors
type diabetes
adipose tissue
skeletal muscle
ionic liquid
smoking cessation